Lindsay Bevan
Research Subjects
Lindsay Bevan has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Katie Hunter
Centre for Effective Practice, 400 University Ave Suite 2100, Toronto, Ontario M5G 1S5, Canada
2 shared publicationsAmanda Van Hal
Manager, Project Solutions, Q2 Solutions
1 shared publication- Andrea Moser
Baycrest Center for Geriatric Care, Toronto, Ontario, Canada; Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada
1 shared publication Anne Dabrowski
Director, Information Services, The Centre for Effective Practice, Toronto, ON
1 shared publicationChristina De Longhi
Specialist, Information Services, The Centre for Effective Practice, Toronto, ON
1 shared publicationEllen Tulchinsky
Manager, Information Services, The Centre for Effective Practice, Toronto, ON
1 shared publication
Latest Publications
- Open Access
- 1 August 2024
- Published by University of Alberta Libraries in Journal of the Canadian Health Libraries Association / Journal de l'Association des bibliothèques de la santé du Canada
- Vol. 45 (2) , 76-87
The COVID-19 Resource Centre: A Tool for Primary Care
Introduction: In March 2020, the Ontario-based Centre for Effective Practice (CEP) launched an online portal that would become the CEP COVID-19 Resource Centre (CRC), one of Ontario’s most well-known and best-used sources for primary care clinical and practice guidance during the COVID-19 pandemic. Description: Authors will describe how key principles of librarianship drove the development and evolution of the CRC, discuss their approach to literature searching and appraisal in a time of great uncertainty and scant evidence, and outline successes and challenges. Outcomes: With over 170,500 visitors since 2020, the CRC became an invaluable tool for primary care providers in Ontario, across Canada and internationally. 89% of site visitors reported that the CRC enhanced their knowledge of COVID-19 evidence, recommendations and policies. 87% of visitors reported that the Vaccine resource directly informed their practice. Discussion: Authors discuss challenges of the rapid-response format and skills formed by the demands of the pandemic.
- 1 August 2024
- Published by University of Alberta Libraries in Journal of the Canadian Health Libraries Association / Journal de l'Association des bibliothèques de la santé du Canada
- Vol. 45 (2) , 76-87
Open AccessThe COVID-19 Resource Centre: A Tool for Primary Care
Introduction: In March 2020, the Ontario-based Centre for Effective Practice (CEP) launched an online portal that would become the CEP COVID-19 Resource Centre (CRC), one of Ontario’s most well-known and best-used sources for primary care clinical and practice guidance during the COVID-19 pandemic. Description: Authors will describe how key principles of librarianship drove the development and evolution of the CRC, discuss their approach to literature searching and appraisal in a time of great uncertainty and scant evidence, and outline successes and challenges. Outcomes: With over 170,500 visitors since 2020, the CRC became an invaluable tool for primary care providers in Ontario, across Canada and internationally. 89% of site visitors reported that the CRC enhanced their knowledge of COVID-19 evidence, recommendations and policies. 87% of visitors reported that the Vaccine resource directly informed their practice. Discussion: Authors discuss challenges of the rapid-response format and skills formed by the demands of the pandemic.
- Open Access
- 11 January 2018
- Published by Oxford University Press (OUP) in International Journal for Quality in Health Care
- Vol. 30 (1) , 65-74
Developing a set of indicators to monitor quality in ambulatory diabetes care using a modified Delphi panel process
There is a large evidence to practice gap in diabetes care with limited performance assessments that capture the full spectrum of care delivery. Our study aimed to develop a set of ambulatory diabetes quality indicators across six domains (effectiveness, safety, patient-centered, timely, equitable and efficient) to provide a broad view of quality. A modified Delphi panel process was conducted. Phase I involved compiling a list of indicators through literature review and generation of patient and healthcare provider-derived indicators through interviews and surveys, respectively. Phase II involved panelists rating indicators using the Agency for Healthcare Research and Quality measure attributes on 9-point Likert scale, attending a face-to-face meeting followed by re-rating, and final ranking. This study was conducted across five adult academic medical centers affiliated with the University of Toronto. A multi-disciplinary Delphi panel (n = 16) including patients was assembled. For indicator advancement for ranking, ≥75% of panelists’ responses in the top tertile (between 7 and 9) with a median composite score of ≥7 was required. There were 202 indicators included in the Delphi panel process including 171 from a comprehensive literature review, 14 from patient interviews, and 17 from healthcare provider surveys. Following the first round, 40 indicators proceeded directly to ranking, while 162 indicators were re-rated and distilled down to 12 for ranking. In the final ranking round, the 52 indicators were reduced to 35 including 13 effective, 10 safe, 6 patient-centered, 1 equitable, 3 efficient and 2 timely indicators. Thirty-five selected indicators developed with broad stakeholder engagement can be used to monitor quality in diabetes care.
- 11 January 2018
- Published by Oxford University Press (OUP) in International Journal for Quality in Health Care
- Vol. 30 (1) , 65-74
Open AccessDeveloping a set of indicators to monitor quality in ambulatory diabetes care using a modified Delphi panel process
There is a large evidence to practice gap in diabetes care with limited performance assessments that capture the full spectrum of care delivery. Our study aimed to develop a set of ambulatory diabetes quality indicators across six domains (effectiveness, safety, patient-centered, timely, equitable and efficient) to provide a broad view of quality. A modified Delphi panel process was conducted. Phase I involved compiling a list of indicators through literature review and generation of patient and healthcare provider-derived indicators through interviews and surveys, respectively. Phase II involved panelists rating indicators using the Agency for Healthcare Research and Quality measure attributes on 9-point Likert scale, attending a face-to-face meeting followed by re-rating, and final ranking. This study was conducted across five adult academic medical centers affiliated with the University of Toronto. A multi-disciplinary Delphi panel (n = 16) including patients was assembled. For indicator advancement for ranking, ≥75% of panelists’ responses in the top tertile (between 7 and 9) with a median composite score of ≥7 was required. There were 202 indicators included in the Delphi panel process including 171 from a comprehensive literature review, 14 from patient interviews, and 17 from healthcare provider surveys. Following the first round, 40 indicators proceeded directly to ranking, while 162 indicators were re-rated and distilled down to 12 for ranking. In the final ranking round, the 52 indicators were reduced to 35 including 13 effective, 10 safe, 6 patient-centered, 1 equitable, 3 efficient and 2 timely indicators. Thirty-five selected indicators developed with broad stakeholder engagement can be used to monitor quality in diabetes care.
- Open Access
- 26 May 2017
- Published by Springer Nature in Implementation Science
- Vol. 12 (1) , 1-14
Improving the appropriateness of antipsychotic prescribing in nursing homes: a mixed-methods process evaluation of an academic detailing intervention
In 2014, nursing home administration and government officials were facing increasing public and media scrutiny around the variation of antipsychotic medication (APM) prescribing across Ontario nursing homes. In response, policy makers partnered to test an academic detailing (AD) intervention to address appropriate prescribing of APM in nursing homes in a cluster-randomized trial. This mixed-methods study aimed to explore how and why the AD intervention may have resulted in changes in the nursing home context. The objectives were to understand how the intervention was implemented, explore contextual factors associated with implementation, and examine impact of the intervention on prescribing. Administrative data for the primary outcome of the full randomized trial will not be available for a minimum of 1 year. Therefore, this paper reports the findings of a planned, quantitative interim trial analysis assessed mean APM dose and prescribing prevalence at baseline and 3 and 6 months across 40 nursing homes (18 intervention, 22 control). Patient-level administrative data regarding prescribing were analyzed using generalized linear mixed effects regression. Semi-structured interviews were conducted with nursing home staff from the intervention group to explore opinions and experiences of the AD intervention. Interviews were analyzed using the framework method, with constructs from the Consolidated Framework for Implementation Research (CFIR) applied as pre-defined deductive codes. Open coding was applied when emerging themes did not align with CFIR constructs. Qualitative and quantitative findings were triangulated to examine points of divergence to understand how the intervention may work and to identify areas for future opportunities and areas for improvement. No significant differences were observed in prescribing outcomes. A total of 22 interviews were conducted, including four academic detailers and 18 nursing home staff. Constructs within the CFIR domains of Outer Setting, Inner Setting, and Characteristics of Individuals presented barriers to antipsychotic prescribing. Intervention Source, Evidence Strength and Quality, and Adaptability explained participant engagement in the AD intervention; nursing homes that exhibited a Tension for Change and Leadership Engagement reported positive changes in processes and communication. Participants described their experiences with the intervention against the backdrop of a range of factors that influence APM prescribing in nursing homes that exist at the system, facility, provider, and resident levels. In this context, the perceived credibility and flexibility of the intervention were critical features that explained engagement with and potential impact of the intervention. Development of a common language across the team to enable communication was reported as a proximal outcome that may eventually have an effect on APM prescribing rates. Process evaluations may be useful during early stages of evaluation to understand how the intervention is working and how it might work better. Qualitative results suggest the lack of early changes observed in prescribing may reflect the number of upstream factors that need to change for APM rates to decrease. ClinicalTrials.gov, NCT02604056
- 26 May 2017
- Published by Springer Nature in Implementation Science
- Vol. 12 (1) , 1-14
Open AccessImproving the appropriateness of antipsychotic prescribing in nursing homes: a mixed-methods process evaluation of an academic detailing intervention
In 2014, nursing home administration and government officials were facing increasing public and media scrutiny around the variation of antipsychotic medication (APM) prescribing across Ontario nursing homes. In response, policy makers partnered to test an academic detailing (AD) intervention to address appropriate prescribing of APM in nursing homes in a cluster-randomized trial. This mixed-methods study aimed to explore how and why the AD intervention may have resulted in changes in the nursing home context. The objectives were to understand how the intervention was implemented, explore contextual factors associated with implementation, and examine impact of the intervention on prescribing. Administrative data for the primary outcome of the full randomized trial will not be available for a minimum of 1 year. Therefore, this paper reports the findings of a planned, quantitative interim trial analysis assessed mean APM dose and prescribing prevalence at baseline and 3 and 6 months across 40 nursing homes (18 intervention, 22 control). Patient-level administrative data regarding prescribing were analyzed using generalized linear mixed effects regression. Semi-structured interviews were conducted with nursing home staff from the intervention group to explore opinions and experiences of the AD intervention. Interviews were analyzed using the framework method, with constructs from the Consolidated Framework for Implementation Research (CFIR) applied as pre-defined deductive codes. Open coding was applied when emerging themes did not align with CFIR constructs. Qualitative and quantitative findings were triangulated to examine points of divergence to understand how the intervention may work and to identify areas for future opportunities and areas for improvement. No significant differences were observed in prescribing outcomes. A total of 22 interviews were conducted, including four academic detailers and 18 nursing home staff. Constructs within the CFIR domains of Outer Setting, Inner Setting, and Characteristics of Individuals presented barriers to antipsychotic prescribing. Intervention Source, Evidence Strength and Quality, and Adaptability explained participant engagement in the AD intervention; nursing homes that exhibited a Tension for Change and Leadership Engagement reported positive changes in processes and communication. Participants described their experiences with the intervention against the backdrop of a range of factors that influence APM prescribing in nursing homes that exist at the system, facility, provider, and resident levels. In this context, the perceived credibility and flexibility of the intervention were critical features that explained engagement with and potential impact of the intervention. Development of a common language across the team to enable communication was reported as a proximal outcome that may eventually have an effect on APM prescribing rates. Process evaluations may be useful during early stages of evaluation to understand how the intervention is working and how it might work better. Qualitative results suggest the lack of early changes observed in prescribing may reflect the number of upstream factors that need to change for APM rates to decrease. ClinicalTrials.gov, NCT02604056
- Open Access
- 25 January 2017
- Published by CMA Impact Inc. in CMAJ Open
- Vol. 5 (1) , E74-E81
Quality indicators for the detection and management of chronic kidney disease in primary care in Canada derived from a modified Delphi panel approach
Background: The detection and management of chronic kidney disease lies within primary care; however, performance measures applicable in the Canadian context are lacking. We sought to develop a set of primary care quality indicators for chronic kidney disease in the Canadian setting and to assess the current state of the disease's detection and management in primary care. Methods: We used a modified Delphi panel approach, involving 20 panel members from across Canada (10 family physicians, 7 nephrologists, 1 patient, 1 primary care nurse and 1 pharmacist). Indicators identified from peer-reviewed and grey literature sources were subjected to 3 rounds of voting to develop a set of quality indicators for the detection and management of chronic kidney disease in the primary care setting. The final indicators were applied to primary care electronic medical records in the Electronic Medical Record Administrative data Linked Database (EMRALD) to assess the current state of primary care detection and management of chronic kidney disease in Ontario. Results: Seventeen indicators made up the final list, with 1 under the category Prevalence, Incidence and Mortality; 4 under Screening, Diagnosis and Risk Factors; 11 under Management; and 1 under Referral to a Specialist. In a sample of 139 993 adult patients not on dialysis, 6848 (4.9%) had stage 3 or higher chronic kidney disease, with the average age of patients being 76.1 years (standard deviation [SD] 11.0); 62.9% of patients were female. Diagnosis and screening for chronic kidney disease were poorly performed. Only 27.1% of patients with stage 3 or higher disease had their diagnosis documented in their cumulative patient profile. Albumin-creatinine ratio testing was only performed for 16.3% of patients with a low estimated glomerular filtration rate (eGFR) and for 28.5% of patients with risk factors for chronic kidney disease. Family physicians performed relatively better with the management of chronic kidney disease, with 90.4% of patients with stage 3 or higher disease having an eGFR performed in the previous 18 months and 83.1% having a blood pressure recorded in the previous 9 months. Interpretation: We propose a set of measurable indicators to evaluate the quality of the management of chronic kidney disease in primary care. These indicators may be used to identify opportunities to improve current practice in Canada.
- 25 January 2017
- Published by CMA Impact Inc. in CMAJ Open
- Vol. 5 (1) , E74-E81
Open AccessQuality indicators for the detection and management of chronic kidney disease in primary care in Canada derived from a modified Delphi panel approach
Background: The detection and management of chronic kidney disease lies within primary care; however, performance measures applicable in the Canadian context are lacking. We sought to develop a set of primary care quality indicators for chronic kidney disease in the Canadian setting and to assess the current state of the disease's detection and management in primary care. Methods: We used a modified Delphi panel approach, involving 20 panel members from across Canada (10 family physicians, 7 nephrologists, 1 patient, 1 primary care nurse and 1 pharmacist). Indicators identified from peer-reviewed and grey literature sources were subjected to 3 rounds of voting to develop a set of quality indicators for the detection and management of chronic kidney disease in the primary care setting. The final indicators were applied to primary care electronic medical records in the Electronic Medical Record Administrative data Linked Database (EMRALD) to assess the current state of primary care detection and management of chronic kidney disease in Ontario. Results: Seventeen indicators made up the final list, with 1 under the category Prevalence, Incidence and Mortality; 4 under Screening, Diagnosis and Risk Factors; 11 under Management; and 1 under Referral to a Specialist. In a sample of 139 993 adult patients not on dialysis, 6848 (4.9%) had stage 3 or higher chronic kidney disease, with the average age of patients being 76.1 years (standard deviation [SD] 11.0); 62.9% of patients were female. Diagnosis and screening for chronic kidney disease were poorly performed. Only 27.1% of patients with stage 3 or higher disease had their diagnosis documented in their cumulative patient profile. Albumin-creatinine ratio testing was only performed for 16.3% of patients with a low estimated glomerular filtration rate (eGFR) and for 28.5% of patients with risk factors for chronic kidney disease. Family physicians performed relatively better with the management of chronic kidney disease, with 90.4% of patients with stage 3 or higher disease having an eGFR performed in the previous 18 months and 83.1% having a blood pressure recorded in the previous 9 months. Interpretation: We propose a set of measurable indicators to evaluate the quality of the management of chronic kidney disease in primary care. These indicators may be used to identify opportunities to improve current practice in Canada.